Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (361-370 of 471) with videos related to

Pageof 48
Sort By:
JACC. Cardiovascular Interventions|December 22, 2012
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialJennifer Yu, Roxana Mehran, George D Dangas, et al.
The American Journal of Cardiology|December 25, 2012
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)Alf Inge Larsen, Dennis W T Nilsen, Jennifer Yu, et al.
The American Journal of Cardiology|January 26, 2002
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])Richard E Kuntz, Donald S Baim, David J Cohen, et al.
Circulation|October 3, 2002
7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)Toru Kataoka, Eberhard Grube, Yasuhiro Honda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2022
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C TrialDariusz Jagielak, Radoslaw Targonski, Christian Frerker, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber, Gregg W Stone, Giora Weisz, et al.
Journal of the American College of Cardiology|July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
Journal of the American College of Cardiology|April 20, 2004
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialGregory G Pellizzon, Cindy L Grines, David A Cox, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trialEugenia Nikolsky, Gregg W Stone, Edwin Lee, et al.
The American Journal of Cardiology|December 28, 2004
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)Thomas D Stuckey, Gregg W Stone, David A Cox, et al.
Pageof 48

Showing results (361-370 of 471) with videos related to

Sort By:
Pageof 48
JACC. Cardiovascular Interventions|December 22, 2012
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trialJennifer Yu, Roxana Mehran, George D Dangas, et al.
The American Journal of Cardiology|December 25, 2012
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)Alf Inge Larsen, Dennis W T Nilsen, Jennifer Yu, et al.
The American Journal of Cardiology|January 26, 2002
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])Richard E Kuntz, Donald S Baim, David J Cohen, et al.
Circulation|October 3, 2002
7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)Toru Kataoka, Eberhard Grube, Yasuhiro Honda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2022
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C TrialDariusz Jagielak, Radoslaw Targonski, Christian Frerker, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber, Gregg W Stone, Giora Weisz, et al.
Journal of the American College of Cardiology|July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
Journal of the American College of Cardiology|April 20, 2004
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialGregory G Pellizzon, Cindy L Grines, David A Cox, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trialEugenia Nikolsky, Gregg W Stone, Edwin Lee, et al.
The American Journal of Cardiology|December 28, 2004
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)Thomas D Stuckey, Gregg W Stone, David A Cox, et al.
Pageof 48